BioClonal oficially inaugurates its new facilities
BioClonal has officially inaugurated its cutting-edge laboratories in Zaragoza, Spain, marking a major milestone in its mission to combat Alzheimer’s disease. The event, attended by over 50 guests including Aragón’s regional president Jorge Azcón, showcased the company’s groundbreaking work in personalized monoclonal antibody research. CEO Paula Garfella highlighted BioClonal’s commitment to addressing complex medical challenges, […]
Jessika Valero receives de IMPULSA Award for Female Leadership
We are thrilled to announce that our Technical Director, Jessika Valero, has been honored with the prestigious IMPULSA Award for Female Leadership. This recognition celebrates exceptional female talent and leadership, acknowledging the drive, career achievements, and future potential of outstanding women in executive roles. Jessika shared this proud moment with fellow honoree Paloma Yarza, President […]
DESAFÍA BOSTON
BioClonal has been selected to represent Spanish biotechnology at the prestigious Desafía Boston program, organized by Richi Entrepreneurs and ICEX. This program offers participants a unique opportunity to expand their international presence and engage with Boston’s thriving biotech community.On October 1st, the first session took place in Madrid, where Pablo Caño delivered an inspiring workshop […]
Festival of Biologics 2024
BioClonal is thrilled to announce our participation in the Festival of Biologics 2024, one of the most significant events in the biotechnology industry. This is an excellent opportunity for us to connect with fellow innovators, researchers, and industry leaders. We warmly invite you to visit us at our stand, number S16, where our knowledgeable team […]
PEGS Europe 2024
BioClonal is thrilled to participate in PEGS Europe 2024, a premier event dedicated to the latest advancements in protein and antibody engineering. This conference provides an excellent platform for industry leaders, researchers, and innovators to come together, share insights, and explore collaboration opportunities. We invite you to join us for engaging discussions about our pioneering […]
BioEurope 2024
BioClonal is thrilled to announce our participation in BioEurope 2024, celebrating 30 years of innovation in the biotechnology industry. This year’s event will take place in the vibrant city of Stockholm, bringing together key players from around the globe to discuss advancements, forge partnerships, and drive innovation in life sciences. We invite you to connect […]
A DAY WITH A BIOTECH WOMAN – AseBio
BioClonal actively participated in the second edition of the #UnDíaConUnaMujerBiotech program, an initiative promoted by the Spanish Bioindustry Association (AseBio) aimed at introducing female students to the professional world of biotechnology. This program offers future scientists the opportunity to closely observe how companies in the sector operate, promoting visibility and female talent in this key […]
PEGS BOSTON
BioClonal proudly participated in the PEGS Boston 2024 Summit, held from May 13th to 17th, where our CEO Paula and CSO Jessika represented the company at one of the most prestigious global conferences in antibody research. The event offered a unique platform for BioClonal to connect with industry leaders, exchange insights, and explore the latest […]
IDEA AWARD
BioClonal has been awarded in the XXIX edition of the IDEA Contest, in the IDEA Project category. This is one of the oldest competitions to recognise entrepreneurial and innovative initiatives in our community and one of the oldest in the country. It is organised by the Department of Industry, Competitiveness and Business Development, through the […]
AIS CONGRESS MONTPELLIER
BioClonal participated in the 12th Antibody Industrial Symposium (AIS Congress), the largest monoclonal antibody event in France, which took place on June 20-21, 2024, at the CORUM Conference Center in Montpellier. The event, organized by LabEx MAbImprove and MabDesign, brought together key players in the biotechnology sector to discuss the latest advancements and foster collaboration.Represented […]